Rare diseases
Investigational molecules
Locations
Wilhelm-Wagenfeld-Strasse 20, Schwabing-Freimann, 80807 Munich, Germany
HMNC Holding GmbH focuses on Major Depressive Disorder, with clinical research centred on depressive symptom management in outpatient settings and the evaluation of targeted approaches for patients with specific biological profiles.
The sponsor’s research activity is concentrated in mood disorder treatment, with interest in patient subgroups defined by polygenic risk markers and related neurobiological characteristics.
HMNC Holding GmbH runs clinical trials in conditions such as Major depression, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
